Ajanta Pharma Limited (BOM:532331)
3,316.65
+46.40 (1.42%)
At close: Nov 20, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 414.5 billion as of November 20, 2026. Its market cap has increased by 31.83% in one year.
Market Cap
414.50B
Enterprise Value
409.24B
Revenue
62.17B
Global Rank
n/a
Country Rank
n/a
PE Ratio
32.83
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 414.50B, an increase of 73,159.47%. That is a compound annual growth rate of 30.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 414.50B | 19.87% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 747.32B |
| Alkem Laboratories | 619.94B |
| Gland Pharma | 549.34B |
| Ipca Laboratories | 466.56B |
| Emcure Pharmaceuticals | 443.66B |
| Ajanta Pharma | 414.52B |
| Wockhardt | 353.36B |
| Piramal Pharma | 317.20B |